Ikena Oncology, Inc.
IKNA
$1.14
-$0.01-0.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 40.50% | 27.77% | 5.06% | -6.28% | -5.97% |
| Total Depreciation and Amortization | -64.48% | -51.96% | -23.68% | -4.24% | 25.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.13% | -25.94% | 23.68% | 27.08% | 18.18% |
| Change in Net Operating Assets | 89.77% | 81.64% | 43.85% | 11.01% | -11.38% |
| Cash from Operations | 51.11% | 42.31% | 18.54% | 0.25% | -5.61% |
| Capital Expenditure | -- | -- | 31.59% | 82.69% | 83.10% |
| Sale of Property, Plant, and Equipment | 525.00% | -- | 10,675.00% | 5,925.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -19.01% | -154.74% | -127.74% | -87.48% | -54.07% |
| Cash from Investing | -16.96% | -154.41% | -127.62% | -87.19% | -53.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | 6,177.50% |
| Repurchase of Common Stock | -- | -- | 100.00% | 83.71% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -99.85% | -- | -- |
| Cash from Financing | -- | -- | -99.92% | 5.27% | 12,563.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -168.93% | -233.99% | -240.07% | -217.04% | 236.36% |